OUTSET MEDICAL INC (OM) Stock Earnings & Estimates
USA - NASDAQ:OM - US6901452069 - Common Stock
4.68 USD
-0.22 (-4.49%)
4.77 USD
+0.09 (+1.92%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 115.4M 12.48% | 130.376M 12.98% | 113.689M -12.80% | 127.86M 12.46% | 141.3M 10.51% | 157.28M 11.31% | 193.33M 22.92% | 216.3M 11.88% | 239.27M 10.62% | |
| EBITDA YoY % growth | -155.83M -24.33% | -164.19M -5.36% | -102.29M 37.70% | -43.054M 57.91% | -42.23M 1.91% | -33.578M 20.49% | -5.871M 82.52% | 5.15M 187.72% | 17.201M 234.00% | |
| EBIT YoY % growth | -161M -23.37% | -170M -5.59% | -108.02M 36.46% | -47.535M 55.99% | -42.642M 10.29% | -35.913M 15.78% | -8.137M 77.34% | 3.09M 137.97% | 14.935M 383.33% | |
| Operating Margin | -139.51% | -130.39% | -95.01% | -37.18% | -30.18% | -22.83% | -4.21% | 1.43% | 6.24% | |
| EPS YoY % growth | -51.15 -18.40% | -46.50 9.09% | -27.00 41.94% | -4.43 83.58% | -2.68 39.49% | -2.31 13.76% | -0.82 64.39% | -0.16 80.00% | 0.67 506.25% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.67 88.47% | -0.60 89.14% | -0.71 78.06% | -0.71 16.01% | -0.57 16.03% | -0.53 11.97% |
| Revenue Q2Q % growth | 31.806M 10.95% | 33.063M 12.20% | 32.239M 8.36% | 34.248M 9.00% | 36.05M 13.34% | 37.595M 13.71% |
| EBITDA Q2Q % growth | -9.407M 52.20% | -8.549M 47.46% | -10.455M 30.40% | -10.403M 28.50% | -8.188M 12.96% | -7.468M 12.65% |
| EBIT Q2Q % growth | -11.559M 51.84% | -10.33M 53.04% | -11.33M 30.53% | -11.176M 34.26% | -8.858M 23.37% | -8.086M 21.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.84 88.09% | -1.01 | 0.17 | 16.99% |
| Q1 2025 Q2Q % growth | -3.24 62.11% | -0.97 | -2.27 | -232.87% |
| Q4 2024 Q2Q % growth | -5.55 37.29% | -6.37 | 0.82 | 12.92% |
| Q3 2024 Q2Q % growth | -5.85 45.07% | -6.51 | 0.66 | 10.20% |
| Q2 2024 Q2Q % growth | -7.05 47.78% | -6.98 | -0.07 | -1.03% |
| Q1 2024 Q2Q % growth | -8.55 36.67% | -8.48 | -0.07 | -0.88% |
| Q4 2023 Q2Q % growth | -8.85 31.40% | -9.50 | 0.65 | 6.86% |
| Q3 2023 Q2Q % growth | -10.65 16.47% | -10.30 | -0.35 | -3.40% |
| Q2 2023 Q2Q % growth | -13.50 2.17% | -11.78 | -1.72 | -14.59% |
| Q1 2023 Q2Q % growth | -13.50 -15.38% | -11.46 | -2.04 | -17.76% |
| Q4 2022 Q2Q % growth | -12.90 1.15% | -13.29 | 0.39 | 2.91% |
| Q3 2022 Q2Q % growth | -12.75 -30.77% | -12.51 | -0.24 | -1.88% |
| Q2 2022 Q2Q % growth | -13.80 -39.39% | -10.78 | -3.02 | -27.97% |
| Q1 2022 Q2Q % growth | -11.70 -11.43% | -11.12 | -0.58 | -5.18% |
| Q4 2021 Q2Q % growth | -13.05 -16.00% | -11.86 | -1.19 | -10.05% |
| Q3 2021 Q2Q % growth | -9.75 80.36% | -11.28 | 1.53 | 13.55% |
| Q2 2021 Q2Q % growth | -9.90 | -10.78 | 0.88 | 8.20% |
| Q1 2021 Q2Q % growth | -10.50 | -12.54 | 2.04 | 16.25% |
| Q4 2020 Q2Q % growth | -11.25 | -10.26 | -0.99 | -9.66% |
| Q3 2020 Q2Q % growth | -49.65 | -47.95 | -1.70 | -3.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 31.419M 14.72% | 30.29M | 1.129M | 3.73% |
| Q1 2025 Q2Q % growth | 29.752M 5.62% | 28.646M | 1.106M | 3.86% |
| Q4 2024 Q2Q % growth | 29.467M -3.41% | 29.328M | 139K | 0.47% |
| Q3 2024 Q2Q % growth | 28.666M -5.59% | 27.712M | 954K | 3.44% |
| Q2 2024 Q2Q % growth | 27.388M -24.01% | 32.123M | -4.735M | -14.74% |
| Q1 2024 Q2Q % growth | 28.168M -15.83% | 31.251M | -3.083M | -9.87% |
| Q4 2023 Q2Q % growth | 30.507M -4.70% | 31.316M | -809K | -2.58% |
| Q3 2023 Q2Q % growth | 30.362M 9.37% | 31.302M | -940K | -3.00% |
| Q2 2023 Q2Q % growth | 36.04M 43.81% | 35.838M | 202K | 0.56% |
| Q1 2023 Q2Q % growth | 33.467M 9.55% | 32.712M | 755K | 2.31% |
| Q4 2022 Q2Q % growth | 32.01M 13.71% | 31.85M | 160K | 0.50% |
| Q3 2022 Q2Q % growth | 27.76M 5.47% | 25.979M | 1.781M | 6.86% |
| Q2 2022 Q2Q % growth | 25.06M -0.63% | 28.316M | -3.256M | -11.50% |
| Q1 2022 Q2Q % growth | 30.55M 33.29% | 31.013M | -463K | -1.49% |
| Q4 2021 Q2Q % growth | 28.15M 63.19% | 27.218M | 932K | 3.42% |
| Q3 2021 Q2Q % growth | 26.32M 91.28% | 25.876M | 444K | 1.72% |
| Q2 2021 Q2Q % growth | 25.22M 114.82% | 24.448M | 772K | 3.16% |
| Q1 2021 Q2Q % growth | 22.92M 218.78% | 22.096M | 824K | 3.73% |
| Q4 2020 Q2Q % growth | 17.25M | 14.167M | 3.083M | 21.76% |
| Q3 2020 Q2Q % growth | 13.76M | 11.908M | 1.852M | 15.55% |
| Q2 2020 Q2Q % growth | 11.74M 309.06% | % | ||
| Q1 2020 Q2Q % growth | 7.19M 188.76% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 25.99% | 0% | 16.73% |
| Revenue | 0.59% | 1.18% | 0.09% | 1.73% |